|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/07/21 Bone Biologics Corp. S-1/A 60:9.2M M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size
1: S-1/A Pre-Effective Amendment to Registration Statement HTML 1.87M
(General Form)
2: EX-5.1 Opinion of Counsel re: Legality HTML 24K
3: EX-10.39 Material Contract HTML 17K
4: EX-10.40 Material Contract HTML 16K
5: EX-10.42 Material Contract HTML 248K
12: R1 Cover HTML 47K
13: R2 Condensed Consolidated Balance Sheets HTML 91K
14: R3 Condensed Consolidated Balance Sheets HTML 36K
(Parenthetical)
15: R4 Condensed Consolidated Statements of Operations HTML 80K
16: R5 Consolidated Statement of Stockholders' Deficit HTML 62K
17: R6 Condensed Consolidated Statements of Cash Flows HTML 78K
18: R7 The Company HTML 57K
19: R8 Summary of Significant Accounting Policies HTML 94K
20: R9 Accounts Payable and Accrued Expenses HTML 26K
21: R10 Notes Payable - Related Party HTML 171K
22: R11 Stockholders? Deficit HTML 100K
23: R12 Stock-based Compensation HTML 161K
24: R13 Income Taxes HTML 79K
25: R14 Related Party Transactions HTML 22K
26: R15 Deferred Compensation HTML 27K
27: R16 Commitments and Contingencies HTML 72K
28: R17 Subsequent Events HTML 24K
29: R18 Summary of Significant Accounting Policies HTML 120K
(Policies)
30: R19 Summary of Significant Accounting Policies HTML 38K
(Tables)
31: R20 Accounts Payable and Accrued Expenses (Tables) HTML 25K
32: R21 Notes Payable - Related Party (Tables) HTML 70K
33: R22 Stockholders? Deficit (Tables) HTML 82K
34: R23 Stock-based Compensation (Tables) HTML 148K
35: R24 Income Taxes (Tables) HTML 75K
36: R25 The Company (Details Narrative) HTML 93K
37: R26 Schedule of Antidilutive Securities Excluded from HTML 29K
Computation of Earnings Per Share (Details)
38: R27 Summary of Significant Accounting Policies HTML 34K
(Details Narrative)
39: R28 Schedule of Accounts Payable and Accrued Expenses HTML 25K
(Details)
40: R29 Schedule of Notes Payable (Details) HTML 48K
41: R30 Notes Payable - Related Party (Details Narrative) HTML 135K
42: R31 Schedule of Warrant Activity (Details) HTML 43K
43: R32 Schedule of Outstanding Vested and Unexercised HTML 49K
Common Stock Warrants (Details)
44: R33 Stockholders? Deficit (Details Narrative) HTML 45K
45: R34 Schedule of Stock Option Activity (Details) HTML 53K
46: R35 Schedule of Outstanding Stock Options (Details) HTML 64K
47: R36 Schedule of Assumptions Using Black-Scholes Option HTML 27K
Pricing Model (Details)
48: R37 Schedule of Non-vested Options (Details) HTML 44K
49: R38 Stock-based Compensation (Details Narrative) HTML 38K
50: R39 Schedule of Provision for Income Taxes (Details) HTML 40K
51: R40 Schedule of Deferred Tax Assets and Liabilities HTML 33K
(Details)
52: R41 Schedule of Income Tax Effective Tax Rate HTML 35K
(Details)
53: R42 Income Taxes (Details Narrative) HTML 27K
54: R43 Deferred Compensation (Details Narrative) HTML 33K
55: R44 Commitments and Contingencies (Details Narrative) HTML 55K
56: R45 Subsequent Events (Details Narrative) HTML 33K
58: XML IDEA XML File -- Filing Summary XML 103K
11: XML XBRL Instance -- forms-1a_htm XML 1.75M
57: EXCEL IDEA Workbook of Financial Reports XLSX 76K
7: EX-101.CAL Inline XBRL Taxonomy Extension Calculation XML 112K
Linkbase Document -- bblg-20210630_cal
8: EX-101.DEF Inline XBRL Taxonomy Extension Definition Linkbase XML 378K
Document -- bblg-20210630_def
9: EX-101.LAB Inline XBRL Taxonomy Extension Label Linkbase XML 872K
Document -- bblg-20210630_lab
10: EX-101.PRE Inline XBRL Taxonomy Extension Presentation XML 622K
Linkbase Document -- bblg-20210630_pre
6: EX-101.SCH Inline XBRL Taxonomy Extension Schema Document -- XSD 131K
bblg-20210630
59: JSON XBRL Instance as JSON Data -- MetaLinks 276± 381K
60: ZIP XBRL Zipped Folder -- 0001493152-21-024979-xbrl Zip 441K
Exhibit 10.40
C:
C:
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/26/24 Bone Biologics Corp. S-1/A 3:393K M2 Compliance LLC/FA 2/23/24 Bone Biologics Corp. S-1/A 7:1.3M M2 Compliance LLC/FA 2/21/24 Bone Biologics Corp. 10-K 12/31/23 63:6.3M M2 Compliance LLC/FA 1/30/24 Bone Biologics Corp. S-1 64:9.1M M2 Compliance LLC/FA 11/20/23 Bone Biologics Corp. 10-K/A 12/31/22 14:425K M2 Compliance LLC/FA 6/13/23 Bone Biologics Corp. S-1/A 6:1M M2 Compliance LLC/FA 6/06/23 Bone Biologics Corp. S-1/A 6:1M M2 Compliance LLC/FA 5/01/23 Bone Biologics Corp. S-1 5:758K M2 Compliance LLC/FA 3/30/23 Bone Biologics Corp. 10-K 12/31/22 58:5.5M M2 Compliance LLC/FA 10/05/22 Bone Biologics Corp. S-1/A 10/04/22 59:8M M2 Compliance LLC/FA 10/04/22 Bone Biologics Corp. S-1/A 59:8M M2 Compliance LLC/FA 9/23/22 Bone Biologics Corp. S-1 58:7.9M M2 Compliance LLC/FA 3/15/22 Bone Biologics Corp. 10-K 12/31/21 59:5M M2 Compliance LLC/FA |